Owkin Alternatives

Get insightful text analysis with machine learning that extracts, analyzes, and stores text. Train high-quality machine learning custom models without a single line of code with AutoML. Apply natural language understanding (NLU) to apps with Natural Language API. Use entity analysis to find and label fields within a document, including emails, chat, and social media, and then sentiment analysis to understand customer opinions to find actionable product and UX insights. Natural Language with speech-to-text API extracts insights from audio. Vision API adds optical character recognition (OCR) for scanned docs. Translation API understands sentiments in multiple languages. Use custom entity extraction to identify domain-specific entities within documents, many of which don’t appear in standard language models, without having to spend time or money on manual analysis. Train your own high-quality machine learning custom models to classify, extract, and detect sentiment.

The cost, complexity and long timeframes associated with evidence generation through traditional approaches prevent agile research and the broader utilization of authentic patient insights in the treatment development and commercial pipelines. Our HyperStream represents the largest real-time patient experience data stream on earth. It captures the real-world digital history of diseases, as they are shared by authentic patients online. Pharos is a web-based evidence generation tool and research framework that uses its integrated data streaming and AI capabilities to efficiently capture online patient experience data and enables teams to quickly discover evidence when they need it. To date, the Pharos Suite has successfully been used to generate evidence and patient insights in multiple therapy areas and diseases.

Diagnosis is the process of determining which disease or health condition explains a person's test results and symptoms. DDxHub - Differential diagnosis Hub is the System distinguishing of a particular disease or health condition from others that present similar symptoms and lab test results. DDxHub is a concentrator that holds a lot of disease descriptions. DDxHub is useful when you try to find a right diagnosis by comparing several different possible diagnoses. You may enter your own disease definition into DDxHub repository and share the disorder descriptions with other DDxHub users around the world. In turn, you will be updated with disorder descriptions from other DDxHub users. Join the thousands healthcare professionals and patients who already love DDxHub's differential diagnosis, sync, and disorders description sharing solution. DDxHub is useful for clinical therapeutics students at medical schools as educational resource.

We are an artificial intelligence-enabled SaaS that diagnoses drug-resistant tuberculosis in a few hours. AarogyaAI aims to diagnose drug-resistant tuberculosis (DR-TB) using Artificial Intelligence in a few hours. We enable quick and accurate diagnosis of DR-TB so that the patient can be rightly prescribed effective drug combinations for treatment, instantly. Tuberculosis claims more lives every year than AIDS. This is because, of the 19 anti-TB drugs available, doctors don’t always know which ones will work for whom. Thus, even though tuberculosis is curable, a delayed diagnosis of drug-resistant tuberculosis can mean patients are on ineffective medication for up to 7 years. AarogyaAI aims to diagnose drug-resistant tuberculosis in a few hours so that a patient can be prescribed effective treatment, instantly. We use a DNA sequence from the patient which is uploaded to our SaaS. Our machine learning algorithm then gives an output report of a comprehensive drug susceptibility status.

Artificial intelligence to transform healthcare diagnosis. Using AI and predictive analytics for early-stage disease detection and accurate diagnosis. Cloud-enabled AI platform to ensure affordable and accessible healthcare for all. Endimension Technology is a healthcare artificial intelligence startup incubated at IIT Bombay. We develop AI algorithms to automatically detect abnormalities and diseases from medical scans. The founding team consists of machine learning researchers, software engineers and medical doctors from reputed institutions. Our mission is to build healthcare AI technology products that will reduce patient misdiagnosis. AI to reduce radiologist workload and improve patient turnaround time.

Pharma companies need comprehensive genomic information to drive successful precision medicine programs, but decisions are often made using only a fraction of the data available, about 10%. Genomenon delivers 100% of the data. An efficient and cost-effective natural history research solution for pharma, ProdigyTM Patient Landscapes support the development of rare disease therapies by enhancing insights contained in retrospective and prospective health data. Using a powerful AI-driven approach, Genomenon delivers a comprehensive and expert assessment of every patient in the published medical literature, in a fraction of the time. Don’t miss anything, get insight into every genomic biomarker published in the medical literature. Every scientific assertion is supported by empirical evidence from the medical literature. Identify all genetic drivers and pinpoint which variants are known to be pathogenic according to ACMG clinical standards.

Altis Labs announces launch of Nota – a clinical information platform to accelerate therapeutic R&D Nota leverages. AI to predict patient outcomes from imaging data so sponsors can better prioritize their most promising therapies. Nota enables researchers to operationalize clinical trial imaging data, access predictive imaging biomarkers, and accelerate R&D at scale. Using Altis’ cloud-based software platform powered by deep learning, biopharma can incorporate comprehensive outcome predictions at the image, patient, and cohort level to improve clinical trial design and more confidently anticipate clinical endpoints. Such insights have the potential to significantly accelerate development timelines, lower drug development costs, and improve the likelihood of trial success across therapeutic areas.

Healthcare professionals & pharmaceutical companies use RetinAI's software platform discovery to manage their data, gain enhanced insights with automatic AI analysis, and supercharge clinical and research workflows. A single data platform to manage & access your data anytime from anywhere. Compatible formats include DICOM-compliant and proprietary formats. Data is harmonized, organized, aggregated & analyzed at scale using AI to extract insights about disease progression, treatment outcomes & progression prediction. Enable participative research across your organization with secured cloud-based access to data. The town square for data, medical, and digital teams. Perform AI-based analysis on your OCT volumes for layer & fluid segmentation. Provide immediate evaluation & centralize your insights in a single platform. Instantly invite collaborators to access and work with datasets with different permission levels.

Our AI products are designed to empower healthcare professionals during key moments in the medical journey. From preventive screenings, early detection, emergency care, institutional disease response and treatment adherence; we're enabling seamless workflow optimization across the care continuum. Collaborating with world-renowned healthcare experts, and training algorithms on unprecedented volumes of data, our AI is developed to uphold the strictest global regulatory standards. Backed by deep data science research our solutions anticipate care needs to aid you in constrained circumstances. Our AI solutions are ready for deployment, whenever and wherever needed. Designed to integrate with existing technological infrastructure, they are configurable with your devices of choice. We offer convenient deployment and scaling procedures while assuring industry-certified data security. Our team is there to support you every step of your AI journey.

Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.

Cleerly is a digital healthcare company transforming the way clinicians approach the treatment of heart disease. We design intelligent clinical technologies to help clinicians precisely identify and define atherosclerosis earlier, so they can provide personalized, life-saving treatment plans for all patients throughout their care continuum. We measure atherosclerosis, plaque build-up in the heart's arteries, not indirect markers such as risk factors and symptoms of the disease. Our AI-enabled digital care pathway offers simpler, faster, more accurate heart disease diagnostics and reporting that's tailored to each stakeholder, improving overall clinical and financial outcomes. Cleerly empowers providers to go beyond traditional measures of heart disease by analyzing, characterizing, and quantifying types of plaque, so they can more accurately determine a patient's risk of heart attack and develop a treatment plan to improve heart health.

We’re ushering in a new era of groundbreaking predictive analytics beginning with healthcare data management, machine learning tools and applications custom-built for the healthcare industry. Designed with the business and delivery of healthcare data in mind, Lumiata’s superior cost and risk predictions consistently outperform legacy methods and are modernizing how risk and care are managed across the broader healthcare space. From underwriting to care management to pharmaceuticals, Lumiata has you covered. Our applications and data science tools enable a flexible and collaborative partnership with payers, providers, and digital healthcare companies. Welcome to the light at the end of your AI tunnel. Equip your data science teams with the ML productivity tools they need. It all starts with our proprietary data preparation and cleansing process in which raw data is autonomously ingested, cleansed, and organized into a consumable format ready for machine learning.

BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illnesses or diseases. We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses. Our models are built on data from thousands of compounds across 7 species, leading to robustness rarely seen in the industry. With a focus on human outcomes, the platform has at its core a translatability engine that transforms insights across species. The BIOiSIMTM platform can be used before the preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation.

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering to industrialize drug discovery. Increased control over biology with tools such as CRISPR genome editing and synthetic biology. Reliable automation of complex laboratory research at an unprecedented scale using advanced robotics. Iterative analysis of, and inference from, large, complex in-house datasets using neural network architectures. Increasing elasticity of high-performance computation using cloud solutions. We are leveraging new technology to create virtuous cycles of learning around datasets to build a next-generation biopharmaceutical company. A synchronized combination of hardware, software and data used to industrialize drug discovery. Reshaping the traditional drug discovery funnel. One of the largest, broadest and deepest pipelines of any technology-enabled drug discovery company.

Chat with a medical generative AI that explains its answers, cites references, updates medical knowledge daily, and lets you add and choose knowledge bases. Pre-load the knowledge base and pre-train the model with 2,300+ reference datasets curated by medical domain experts, including hundreds of terminologies, medical research, clinical trials, patents, population health, cost, and public and regulatory data. Multiple sources of medical research and data sources indexed. Daily updates of new medical results, clinical trials, and terminologies. Ready to process millions or billions of documents. Scale the cluster to fit your needs. A medical chatbot is a type of conversational AI that uses natural language processing (NLP) to interact with users and provide them with medical information, advice, or support. They can be used for a variety of purposes. Answer general medical questions about diseases, health conditions, and treatment options.

Improving the quality of care and outcomes for cancer patients requires collaboration between physicians, scientists, cancer centers, and patients. Oncora's intuitive software platform allows all stakeholders to capture and apply real-world data for all healthcare-related decisions, for the benefit of the patient. Our products are built for healthcare professionals dedicated to improving cancer outcomes. Simplify workflow, reduce documentation burden, and optimize treatment with intelligent patient care software. Capture and visualize regulatory-grade real-world data with intuitive and dynamic software tools. Measure quality and streamline operations to improve care with advanced reporting tools. Rigorous clinical research with top cancer care professionals. Intuitive, web-based software to power your cancer center. Data and software to accelerate clinical discoveries.

Many decisions in cancer care are uncertain and current tools are not helping the majority of cancer patients. This is leading to unnecessary loss of life and billions of dollars of wasted cost. We are a team of multidisciplinary computer scientists and oncologists helping tackle the most pressing questions in cancer care through AI. We are building clinical grade deep learning to analyze each patient's characteristics and provide clarity to oncologists during decision making. Our AI is built with oncologists at the center and provides interpretable and actionable insights. We work with top academic medical centers and community oncologists to answer clinically important questions.

WRDensity assists radiologists in interpreting breast density to create uniformity of density assessments at a practice level. The goal, aid in early detection¹ while giving patients peace of mind by improving consistency, confidence, and quality of care. WRDensity was trained using deep learning based on over 600,000 images from Mallinckrodt Institute of Radiology, one of the world’s leading radiology research institutes. WRDensity’s powerful deep learning model delivers highly accurate breast density classification. Our batching and sorting feature delivers up to a 20% increase in productivity for users of the product. WRDensity is presented within the radiologist’s existing workstation making relevant tissue density information available in context.

At Genospace, we understand that genomics is driving the development of precision medicine, yet scaling its delivery is an unsolved challenge. We’re here to help. Our platform is designed to make biomedical data meaningful and accessible to everyone, especially those on the front lines of care delivery. Arm your clinicians and researchers with the information they need to make informed decisions and join us in our mission of leveraging high-dimensional molecular data to improve individual patient outcomes and accelerate drug development and research. Large-scale population data is necessary for drug development and research. Conduct cohort-driven analyses to inform your research activities with the Genospace platform. We specialize in clinical trial research. Use the Genospace platform to match fragmented patient data to complex trial criteria and expedite patient accruals. Integrate genomic medicine into mainstream clinical care with the Genospace platform.

Zebra’s Imaging Analytics Engine receives imaging scans from various modalities and automatically analyzes them for a number of different clinical findings, in a timely manner and full synergy with radiology workflow. Providers use Zebra-Med to alert them of patients at high risk of cardiovascular, lung, bone and other diseases. This facilitates preventative care programs, proper risk adjustments and allocation, as well as conformance with quality standards such as MACRA. With Zebra-Med – focus can be provided to the right patients, at the right time – saving overall costs while improving care.

Medical AI is a true technology solution that comprehensively addresses chronic diseases. The hallmarks of this technology are its ability to predict, generate the next-best actions, and present the outputs in an easy-to-consume user experience. DeLorean Medical AI augments human capabilities and creates a future where we can trust both the machine and the human to make the best decisions. Our technology has been shown to improve outcomes and is the first AI to be biologically validated through third-party clinical tests. With the ability to better classify patient populations, assign risk, and predict disease state transitions, Medical AI directly leads to earlier detection and diagnosis of diseases. It can also reduce costs. Having been installed for 10+ clients, it has demonstrated both cost reductions and savings associated with real-time predictions to determine at-risk populations and next-best-action recommendations based on statistical probabilities.

Leverage the power of AI to expedite the journey from bench research and laboratory insights to the launch of life-changing therapies. Gain up to 90% in research productivity by reducing your reading time from months to minutes. Cut through the noise with a high-precision, high-accuracy search to navigate the ever-growing volume of scientific literature with ease. Save time, reduce bias and increase odds of novel discoveries. Deeply explore disease biology and conduct advanced target discovery. Causaly’s high-precision knowledge graph consolidates evidence from millions of publications, making deep, unbiased scientific exploration possible. Rapidly navigate biological cause-and-effect relationships without being an expert. Get a view of all scientific documents and uncover hidden connections. Causaly’s powerful AI machine reads millions of published biomedical literature to support better decision-making and research outcomes.

Our regulatory compliant platform empowers clinical research by algorithmically analyzing unstructured EMR data for life endangering conditions. We build technologies that expand access to the most Innovative Healthcare through Clinical Trials. We are a team focused on saving lives by providing access to healthcare therapeutic innovations that are still under investigation. We believe that every patient should be empowered and educated on their opportunities to participate in clinical trials that may offer therapies significantly saving or improving their lives. We are an advanced healthcare AI research company that have developed a computational-based platform to identify patients who match a complex set of criteria to participate in clinical trials.

Accuracy, speed, confidence. Introducing generative AI to commercial biopharma. Simplify the labor-intensive process of collecting, organizing, and inspecting vast amounts of complex data. Get straight to decision-critical insights with 100% confidence, every time. With our AI-powered data manipulation and verification platform, you'll never lose track of your workstreams again. Gather, refine, and check your data, all in one place. Search public and private databases by key drug characteristics. Segment drugs and trials by detailed patient profiles. Extract the data you need in plain English. Support your findings by linking answers back to their source. Focus your time and energy on synthesizing high-quality outputs from data rather than menially sifting through it. Our specialized LLMs enable researchers to perform asset scans 4.8x faster than by hand. We index over 38M scientific publications, conference abstracts, and clinical trials. All the data you need, when you need it.

Story Health uses virtual care and AI technology to bridge the gap between clinical data and patient reality, empowering specialists to optimize treatment for patients with serious illnesses. Most of a patient's health story doesn't happen in a doctor's office. For high-acuity patients, this has meant disjointed solutions and missed opportunities to provide the best possible care. Story Health introduces a new way to treat high morbidity conditions that is more adaptive, quicker to implement and more effective for clinicians and patients alike. Now clinicians have the tools to stay connected to patients, manage complex data streams and make real-time changes to home treatment plans that have critical consequences. Story Health delivers personalized recommendations based on a patient’s specific story and a clinician’s practice patterns. With visibility in-between visits and across patients, it’s easy to identify which patients need attention, swift intervention or therapy optimization.

WellAI for Medical Providers: The First Integrated AI Patient Engagement/Digital Front Door Application with Front Office Optimization. One of the first AI/Natural Language Processing Patient Engagement Platforms/Digital Front Door solutions that offers configurable technology enabled services that integrated with front office workflows driving efficiency and streamlined, real time patient care. Why WellAI's Solution: 1. The Digital Health Virtual Triage Assistant offers an 83% accuracy versus the 50% - 77% accuracy of competitive 'symptom checkers' 2. We offer built in telehealth and can integrate with incumbent telehealth solutions - reducing cost and improving engagement 3. WellAI not only supports 'technology enabled services' in a configurable fashion for patients, but creates automation for the healthcare's front office workflow. 4. It is fully configurable. 5. It can integrate with many EMR solutions. 6. It offers real-time text/email with practitioners.

OM1 uses AI and big clinical data to dramatically improve research efficiency and clinical decision-making through high performance predictive models. OM1 Patient Finder uses proprietary, cutting-edge AI technology integrated with the OM1 Real-World Data Cloud. It incorporates different aspects of patients’ journeys from our range of data sources to identify patients at the greatest likelihood of having the target condition. We’ve built an intelligent data cloud to enable different healthcare stakeholders to cost-effectively access, analyze, and use outcomes data in a more robust, clinically meaningful, and precise way. Quickly, accurately, and more cost-effectively get to research-grade information on effectiveness, value, and safety. Quantify outcomes and demonstrate value in risk-sharing and outcomes-based payment models.

Two decades of partnering with thought leaders to discover, understand, and mitigate sources of error from biopsy to data, led to breakthroughs in tissue data mining tools, precision, workflow, and automation. Learn more about image analysis & tissue mining in multi and highplexed images, mine your data for clinically relevant patterns that lead to disease insight, and transform your research tissue images into knowledge. Learn more about image analysis CE-IVD APPs and workflows, and shift the paradigm on standardization with AI-driven pathology solutions that provide diagnostic decision support. The app center is your gateway to our extensive library of ready-to-run AI-based apps as well as APPs that scale to meet your needs. Browse through our library of publications, guides, webinars, and posters and learn about digital pathology and how our software supports our customers.

Amazon Comprehend Medical is a HIPAA-eligible natural language processing (NLP) service that uses machine learning to extract health data from medical text–no machine learning experience is required. Much of health data today is in free-form medical text like doctors’ notes, clinical trial reports, and patient health records. Manually extracting the data is a time consuming process, while automated rule-based attempts to extract the data don’t capture the full story as they fail to take context into account. As a result, the data remains unusable in large-scale analytics needed to advance the healthcare and life sciences industry and improve patient outcomes and create efficiencies.

MedGeo is a health MedGEO reconnecting healthcare providers with patients through clinician-developed state-of-the-art digital technology. For startups that work directly with providers, administrators, and industry representatives to develop software applications for optimizing clinical workflows. MedGEO is built upon the expertise of renowned global health, surgical, and medical professionals. With decades of first-hand experience across over 100 countries, we bring a unique perspective to the field of healthcare technology. Modern hospital hallways are crowded with computers, piled with hardware, and draped with wires, representing a patchwork of systems that often fail to communicate with one another. Staff are more likely to interact with computers than patients and clinicians spend more time entering data than providing care. MedGEO optimizes workflows for clinicians, healthcare administrators, pharmaceutical companies, and the medical asset industry.

Polyfins Technology Inc is a Silicon Valley startup that applies technologies such as Artificial Intelligence to solve Dermatology problems. It combines the availability of mobility with the power of AI to provide an easy-to-use solution for patients and healthcare providers. To improve the accessibility and accuracy of patient care in developed and developing countries that exploit natural language processing and enable innovative healthcare solutions in the field of dermatology. Our AI-enabled application Eczemaless and Tibot empowers users to access quality skincare information from home. EczemaLess is an AI-enabled application for people suffering from Eczema. It provides a one-stop solution for eczema right from tracking Eczema severity, managing triggers and a personalized care routine. Understand what triggers could be causing your eczema. Evaluate which treatments work best for you. Get general trends for triggers, eczema severity, and care routine.

Empower your healthcare with the game-changing Soliton® AI. Built on 30,000 evidence-based rules and machine learning, Soliton® automates your healthcare and care management tasks. Soliton® gives you the edge to succeed in the world of value-based care with unparalleled capabilities. Analyzes massive sets of patient data in real-time to drive improvement in clinical and financial performance. Supports multiple APMs. Adds value to telehealth by predicting billable codes during the patient encounter. Predicts future healthcare costs for your patients using multiple risk stratification models. Real-time clinical decision support to help you manage complex patient populations. Streamlines the patient journey and care from the acute to the post-acute environment using AI-enhanced care coordination. Identify care gaps, identify service and coding opportunities, generate patient-specific assessments, generate personalized care plans, and build custom cohorts.

InformAI has a healthcare focus on AI solutions that speed up medical diagnosis at the point-of-care and improve radiologist productivity. Our AI-enabled image classifiers and patient outcome predictors are developed within the world’s largest medical center complex, the Texas Medical Center. Together with our partners, InformAI is transforming the way healthcare is being delivered. InformAI works with renowned healthcare organizations, national physician groups, and leading medical imaging companies to build solutions that improve patient outcomes. Our team is comprised of leaders in healthcare, medicine and artificial intelligence. The InformAI Sinus Image Classifier is built using a 3D convolutional neural network (CNN) trained on a radiology-validated 3D CT-scan image library consisting of 6 million medical images.

We automate clinical tasks so you can focus on what matters most, taking care of your patients. Embedded within the EHR, Regard scans the entire patient record and makes sense of that data so you can better diagnose and treat your patients. Regard is proven to dramatically improve hospital finances, patient safety, and physician happiness. Regard reduces coding queries, insurance denials, and time spent reviewing the chart. Join us in our mission to bring world-class healthcare to everyone. Regard was purposefully designed for physicians to streamline workflow, enabling a more efficient and enjoyable use of the EMR. Regard’s AI co-pilot embeds into the EMR and works as a virtual medical resident to curate all patient data, suggest new diagnoses, and automatically generate clinical notes. With Regard, you will spend less time chasing data in the EMR and more time doing what you love. Regard's AI co-pilot embeds directly into your medical record.

Speech is a complex process involving the lungs, upper airways, nerves, and muscles. Signatures found in breath and speech, are indicators of many medical conditions, including respiratory diseases and infections. Mucus, obstruction, congestion, inflammation, scarring, and more have unique auditory signatures. Even before considering the added impact of coronavirus, lower respiratory tract infections cause nearly 4 million deaths per year globally. Climate change has contributed to increases of wildfires and allergenic air pollutants. Use the phone you already have without any professional assistance. A unique framework to capture respiratory sounds in real-world settings, providing real-time feedback and denoising to optimize data quality. We extract dozens of features - many undetectable by the human ear - to power our best-in-class algorithms.

Augnito combines the power of Speech Recognition AI with ease of mobility. You can edit, format, and complete reports at the speed of human speech, with best-in-class accuracy. Now use your personal templates and short forms from any workstation whether you are in the office, or at home or in the journey in between. Best suited for clinical specialties producing detailed reports such as Radiology, Histopathology and Surgical Notes, you can now dictate your reports from anywhere in the world. Augnito understands diverse accents and pronunciations out-of-the-box with no profile training. Built with the latest deep learning technology, it has the entire language of medicine which covers 50+ specialties and sub-specialties combined with all popular generic and drug names.

Using RNA sequencing (RNA-seq) data and Artificial Intelligence are both a necessity and an opportunity to develop therapeutics that target splicing errors. The use of machine learning enables us to discover new splicing errors and quickly design therapeutic compounds to correct them. SpliceCore is our dedicated AI platform for RNA therapeutics discovery. We developed this technology platform specifically for the analysis of RNA sequencing data. It can identify, test and validate hypothetical drug targets faster than traditional methods. At the heart of SpliceCore is our proprietary database of more than 5 million potential RNA splicing errors. It is the largest database of splicing errors in the world and it is used to test every RNA sequencing dataset that is input for analysis. Scalable cloud computing enables us to process massive amounts of RNA sequencing data efficiently, at higher speed and lower cost, exponentially accelerating therapeutic innovation.

A fully autonomous, AI-enabled medical scribe with improved CDI scribing abilities, S10.AI's S10 Robot Medical Scribe lessens the burden of clinical documentation. It delivers quick documentation and integrates with all EHR types. It is based on the patent-pending technology Intelligent Physician Knowledge Orchestrator. The documentation burden will be lessened thanks to S10.AI, giving you more time to see patients. S10.AI stands apart because of: 1. Its accuracy rate for speech-to-text is 99%. 2. Within five minutes, there is immediate documentation. 3. The robot scribe service is accessible both online and offline, around-the-clock. 4. It's 100% automatic EHR data entry is not integrated 5. Highest level of security HIPAA compliant. Utilizing S10.AI allows you to earn more money while spending less on another scribing, transcription, or dictation services.

Enlitic focuses the power of artificial intelligence into data management applications, enabling effective administration, processing, and sharing of patient data throughout the healthcare enterprise. The Enlitic Framework standardizes, protects, integrates, and analyzes medical imaging data to create the foundation of a real-world evidence platform that improves clinical workflows, increases efficiencies, and expands capacity. ENDEX™ standardizes your data. By using computer vision and natural language processing, ENDEX maps DICOM and metadata to consistent and standardized study descriptions enabling consistent hanging protocol displays, accurate data routing, improved billing capabilities and administrative staff can reclaim time from fixing hanging protocols or searching for studies. ENCOG™ is designed to de-identify medical imaging data while retaining clinically relevant information, saving you time and resources.

Plug’n play API to integrate with your diabetes management platform. Personalized therapeutic education. Better insights on BGL fluctuations. Real-time prediction to anticipate risks. Allow for more personalization and better regulation of the system. Handle complex living phases with rapid glucose changes. Telemedicine & retrospective analysis. Decision-support for patients. Hillo is currently working on the next versions of its AI technology, a therapeutic recommendation system to anticipate and prevent hypoglycemia and hyperglycemia, whose CE mark class IIB is planned for 2020, and the new generation of artificial pancreas(AP) for 2021, which will help overcome the main limitations of current AP systems thanks to the ultra-personalization provided by machine learning. The first self-learning artificial intelligence for predicting blood glucose levels to obtain CE mark as a medical device.

Our AI technology enables healthcare providers to perform high-quality ultrasound exams wherever and whenever patients need them, regardless of their familiarity with ultrasound. Ultrasound is a safe, highly effective diagnostic tool, but it can be difficult to master, takes years of specialized training to learn, and image quality can vary. Performing the exam involves unnatural hand-eye coordination and unintuitive visuals. Traditional ultrasound software doesn’t provide instruction on how to move the ultrasound transducer to capture an image, or any real-time feedback on the quality of images being captured. Poor quality images lead to missed opportunities, misdiagnosis, repeat studies, and inconsistent interpretation. As a result, the true value and benefits of ultrasound have not been fully realized. Now, with our technology, any healthcare professional can capture diagnostic-quality ultrasound images thanks to AI guiding them through every step of the scanning process.

Arterys is the medical imaging AI platform allowing you to weave leading AI clinical applications directly into your existing PACS or EHR driven workflow to make it a natural extension of what you already do. We are making AI real by improving physician experience, accuracy of diagnosis and treatment, financial performance and outcomes that matter to patients and providers. Accessible anywhere from any validated device via the cloud for faster performance, ease of deployment with no PHI exchange and completely secure. Connected to your PACS, RIS, EMR and dictation software, Arterys is a seamless part of your workflow. Rapid deployment with minimal on-prem infrastructure. Commercially available in over 100 countries. Our elastic cloud GPU architecture accelerates the performance of all tasks. Like rendering 3D files, Gb large multi-dimension data or running multiple AI applications in real time. Pre-fetch and image caching ensure faster loading and analysis.

Partnering with leading healthcare organizations, harrison.ai creates AI-as-a-medical device solutions that have a global impact and support clinical excellence. At harrison.ai, we believe that high-quality healthcare is a fundamental human right. It should be accessible to all, no matter where we are in the world. To make this vision a reality, we combine medical insights with industry-leading data engineering and harness the potential of artificial intelligence (AI) to deliver a fairer, brighter future for healthcare. By bringing together the greatest minds, we’re cultivating a place that encourages outstanding work and bold, new ideas. We are a clinician-led healthcare artificial intelligence company that innovates efficient and accessible solutions and services. By combining exceptional deep learning expertise with clinical experience we deploy healthcare AI solutions.

Gesund is the world’s first compliant AI factory on a mission to help bring clinical-grade AI solutions to market. To help comply with regulatory requirements, our platform audits and validates 3rd party medical AI solutions for safety, effectiveness, and equity. Gesund orchestrates the entire AI/ML lifecycle for all stakeholders by bringing models, data, and experts together in a no-code environment. Standardized, unified, and diversified data customized for your ML needs and regulatory requirements. Gesund.ai assesses model validation needs and provides a suitable mix of high-quality data from its multiple and diverse clinical partner sites. Model owner shares clinical study with Gesund.ai for curation of appropriate dataset(s), and uploads their model onto Gesund.ai's federated validation platform, which resides on hospital premise or private cloud. The model runs against a previously unseen validation data set that has been curated on the hospital side.

Sargas Pharmaceutical Adherence and Compliance (SPAC) International has developed a proprietary Chronic Care Management Cloud® platform (CCM), Drug Adherence®, Medication Therapy Monitoring® (MTM), and Mobile Oncology Medication Therapy Monitoring® technologies to keep physicians and patients engaged from the time treatment is initiated through the entire treatment process. This team approach to treatment management not only enables patients to reap maximum benefits and achieve the best outcomes but also, reduces costs to the healthcare system. The HIPAA Compliant and certified SPAC Chronic Care Management Physician, Patient, and Pharmacy Portals® allow for real-time, critical patient health information exchange among various providers.

Morressier provides professional and academic organizations with comprehensive virtual and hybrid conference solutions, powerful data and analytics, and new revenue opportunities. Since 2014, more than 200 societies, institutions, and corporations around the world trust Morressier to support their meetings, engage their users, and amplify their research. Partners use Morressier’s powerful suite of tools and custom integrations to host, share, and fully integrate traditionally hidden conference content, including abstracts, posters, presentations, video, and datasets. At the same time, by increasing the dissemination of this early-stage research and providing valuable aggregate insights, Morressier facilitates scholarly discourse and accelerates scientific breakthroughs.

AIDDISON™ drug discovery software combines the power of artificial intelligence (AI), machine learning (ML), and 3D computer-aided drug design (CADD) methods to act as a valuable toolkit for medicinal chemistry needs. As a unified platform for efficient and effective ligand-based and structure-based drug design, it integrates all the facets for virtual screening and supports methods for in-silico lead discovery and lead optimization.

We use our AI engine to transform drug discovery. Our discoveries help create better medicines faster. Our AI-enabled discovery portfolio includes wholly-owned and co-developed pipeline assets, and is backed by prominent investors. Atomwise developed a machine-learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small-molecule medicines. The secret to reinventing drug discovery with AI is people. We are dedicated to developing the best AI platform and using it to transform small molecule drug discovery. We have to tackle the most challenging, seemingly impossible targets and streamline the drug discovery process to give drug developers more shots on goal. Computational efficiency enables screening of trillions of compounds in silico, increasing the likelihood of success. Demonstrated exquisite model accuracy, overcoming the challenge of false positives.

Oncoustics is creating and deploying advanced and patented AI solutions for low-cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical needs. Oncoustics offers a suite of disease and anatomy-focused apps that work on any PoC ultrasound and can be used by any MD/nurse/tech as a basic primary care office instrument, without the need to look at images. Oncoustics’ AI solutions turn the inexpensive point-of-care ultrasound devices into powerful diagnostic tools for faster, cost-effective detection and monitoring of diseases including diseases in the liver, prostate, kidney, breast, and thyroid. Our team is made up of experts in AI, signal processing, radiology, hepatology, digital health, and ultrasound. Inexpensive point of care diagnosis and surveillance improves outcomes through early detection and monitoring resulting in effective disease management.

Machine learning can now do some extraordinary things: it can understand the world, drive cars, write code, make art. But, it's still extremely hard to use. Research is typically published as a PDF, with scraps of code on GitHub and weights on Google Drive (if you’re lucky!). Unless you're an expert, it's impossible to take that work and apply it to a real-world problem. We’re making machine learning accessible to everyone. People creating machine learning models should be able to share them in a way that other people can use, and people who want to use machine learning should be able to do so without getting a PhD. With great power also comes great responsibility. We believe that with better tools and safeguards, we'll make this powerful technology safer and easier to understand.